43017 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 23
00:12 UTC
|
ERIC
Ericsson
|
↓ Downgrade | Terrance Tsul not yet tracked | Equal Weight→ Underweight | $11.00→ $9.00-18.2% |
|
Sep 23
00:12 UTC
|
DAVA
Endava
|
↓ Downgrade | Maggie Nolan ★★★★☆ #592 | Market Perform→ Underperform | |
|
Sep 23
00:12 UTC
|
CMPX
Compass Therapeutics
|
↓ Downgrade | Robert Driscoll ★★☆☆☆ #2507 | Neutral | $1.00 |
|
Sep 23
00:12 UTC
|
BRBY
Burberry Group
|
↓ Downgrade | firm only | Sec→ r perform | GBX 1,400→ GBX 1,200-14.3% |
|
Sep 23
00:12 UTC
|
BEAT
HeartBeam
|
↓ Downgrade | Yi Chen ★★☆☆☆ #2598 | Buy→ Neutral | |
|
Sep 23
00:12 UTC
|
BCAX
Bicara Therapeutics
|
↓ Downgrade | firm only | Equal Weight | |
|
Sep 23
00:12 UTC
|
WST
West Pharmaceutical Services
|
↑ Upgrade | Kallum Titchmarsh ★★★★★ #79 | Equal Weight→ Overweight | $365.00→ $400.00+9.6% |
|
Sep 23
00:12 UTC
|
VLEEY
Valeo
|
↑ Upgrade | firm only | Hold→ Buy | |
|
Sep 23
00:12 UTC
|
RNR
RenaissanceRe
|
↑ Upgrade | firm only | Hold→ Market Outperform | |
|
Sep 23
00:12 UTC
|
QNCX
Quince Therapeutics
|
↑ Upgrade | Jonathan Wolleben ★★☆☆☆ #2594 | Market Perform→ Outperform | $77.00 |
|
Sep 23
00:12 UTC
|
QNCX
Quince Therapeutics
|
↑ Upgrade | firm only | Market Perform→ Outperform | |
|
Sep 23
00:12 UTC
|
OMER
Omeros
|
↑ Upgrade | Olivia Brayer Saunders not yet tracked | Neutral→ Overweight | $22.00 |
|
Sep 23
00:12 UTC
|
MET
MetLife
|
↑ Upgrade | Paul Newsome ★★★★★ #195 | Neutral→ Overweight | $99.00→ $110.00+11.1% |
|
Sep 23
00:12 UTC
|
HFWA
Heritage Financial
|
↑ Upgrade | firm only | Neutral→ Buy | $33.00 |
|
Sep 23
00:12 UTC
|
FITB
Fifth Third Bancorp
|
↑ Upgrade | Benjamin Gerlinger not yet tracked | Neutral→ Buy | $59.00→ $62.00+5.1% |
|
Sep 23
00:12 UTC
|
EPM
Evolution Petroleum
|
↑ Upgrade | Sergey Pigarev ★★★★★ #271 | Hold→ Buy | $4.50 |
|
Sep 23
00:12 UTC
|
ELD
Eldorado Gold
|
↑ Upgrade | firm only | Underperform→ Buy | C$32.00→ C$54.00+68.8% |
|
Sep 23
00:12 UTC
|
EGO
Eldorado Gold
|
↑ Upgrade | Lawson Winder ★★★☆☆ #1691 | Underperform→ Buy | $32.00→ $54.00+68.8% |
|
Sep 23
00:12 UTC
|
EAT
Brinker International
|
↑ Upgrade | Jim Sanderson not yet tracked | Neutral→ Buy | $275.00 |
|
Sep 23
00:12 UTC
|
DANOY
Danone
|
↑ Upgrade | firm only | Sell→ Hold | |
|
Sep 23
00:12 UTC
|
CWK
Cranswick
|
↑ Upgrade | firm only | Buy | GBX 5,770→ GBX 6,080+5.4% |
|
Sep 23
00:12 UTC
|
AM
Antero Midstream
|
↑ Upgrade | firm only | Equal Weight→ Overweight | $25.00 |
|
Sep 22
23:12 UTC
|
CMPX
Compass Therapeutics
|
↓ Downgrade | Robert Driscoll ★★☆☆☆ #2507 | Neutral | $1.00 |
|
Sep 22
22:12 UTC
|
CMPX
Compass Therapeutics
|
↓ Downgrade | firm only | Neutral | |
|
Sep 22
19:12 UTC
|
TA
TransAlta
|
◎ Target | firm only | C$26.00→ C$24.50-5.8% | |
|
Sep 22
19:12 UTC
|
STAA
STAAR Surgical
|
◎ Target | Young Li ★★☆☆☆ #2685 | Buy | $28.00→ $23.00-17.9% |
|
Sep 22
19:12 UTC
|
H
Hydro One
|
◎ Target | firm only | C$59.00→ C$56.00-5.1% | |
|
Sep 22
19:12 UTC
|
FTS
Fortis
|
◎ Target | firm only | C$82.00→ C$78.00-4.9% | |
|
Sep 22
19:12 UTC
|
EMA
Emera
|
◎ Target | firm only | C$76.00→ C$72.00-5.3% | |
|
Sep 22
19:12 UTC
|
ELD
Eldorado Gold
|
◎ Target | firm only | C$55.00→ C$63.00+14.5% | |
|
Sep 22
19:12 UTC
|
DHT.UN
DRI Healthcare Trust
|
◎ Target | firm only | Outperform | C$23.50→ C$25.50+8.5% |
|
Sep 22
19:12 UTC
|
CU
Canadian Utilities
|
◎ Target | firm only | C$55.00→ C$52.00-5.5% | |
|
Sep 22
19:12 UTC
|
CPX
Capital Power
|
◎ Target | firm only | C$83.00→ C$80.00-3.6% | |
|
Sep 22
19:12 UTC
|
AQN
Algonquin Power & Utilities
|
◎ Target | firm only | C$6.25→ C$6.00-4.0% | |
|
Sep 22
19:12 UTC
|
ACO.X
ATCO
|
◎ Target | firm only | C$88.00→ C$85.00-3.4% | |
|
Sep 22
19:12 UTC
|
ELD
Eldorado Gold
|
↑ Upgrade | firm only | Underperform→ Buy | C$32.00→ C$54.00+68.8% |
|
Sep 22
18:12 UTC
|
TPB
Turning Point Brands
|
◎ Target | Ian Zaffino ★★★☆☆ #1904 | Outperform | $130.00→ $90.00-30.8% |
|
Sep 22
18:12 UTC
|
GKOS
Glaukos
|
◎ Target | Michael Sarcone ★★★☆☆ #1356 | Buy | $190.00→ $210.00+10.5% |
|
Sep 22
18:12 UTC
|
ELE
Elemental Royalty
|
◎ Target | Heiko F. Ihle not yet tracked | Buy | $33.00→ $31.00-6.1% |
|
Sep 22
18:12 UTC
|
APH
Amphenol
|
◎ Target | Andrew Buscaglia ★★☆☆☆ #2287 | Outperform | $107.50→ $110.00+2.3% |
|
Sep 22
18:12 UTC
|
ANIX
Anixa Biosciences
|
◎ Target | Yi Chen ★★☆☆☆ #2598 | Buy | $7.00→ $6.00-14.3% |
|
Sep 22
18:12 UTC
|
AA
Alcoa
|
◎ Target | Vitaly Kononov ★★★☆☆ #1671 | Buy | $64.00→ $76.00+18.8% |
|
Sep 22
18:12 UTC
|
NFLX
Netflix
|
↓ Downgrade | Mohammed Khallouf ★★★☆☆ #1313 | Buy→ Hold | $96.00→ $76.00-20.8% |
|
Sep 22
18:12 UTC
|
EPM
Evolution Petroleum
|
↑ Upgrade | Sergey Pigarev ★★★★★ #271 | Hold→ Buy | $4.50 |
|
Sep 22
17:12 UTC
|
SOUN
SoundHound AI
|
◎ Target | James Fish ★★★★☆ #534 | Neutral | $7.00→ $6.00-14.3% |
|
Sep 22
17:12 UTC
|
MSI
Motorola Solutions
|
◎ Target | James Fish ★★★★☆ #534 | Overweight | $530.00→ $531.00+0.2% |
|
Sep 22
17:12 UTC
|
MSFT
Microsoft
|
◎ Target | Brian Schwartz ★★★☆☆ #1910 | Outperform | $515.00→ $570.00+10.7% |
|
Sep 22
17:12 UTC
|
KBR
KBR
|
◎ Target | Ian Zaffino ★★★☆☆ #1904 | Outperform | $60.00→ $50.00-16.7% |
|
Sep 22
17:12 UTC
|
CNTB
Connect Biopharma
|
◎ Target | Mazahir Alimohamed not yet tracked | Outperform | $5.00 |
|
Sep 22
16:12 UTC
|
TWLO
Twilio
|
◎ Target | Derrick Wood ★★★★☆ #341 | Buy | $260.00→ $300.00+15.4% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.